These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7965773)

  • 1. m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine are partial agonists at cloned 5-HT2A receptors expressed in fibroblasts.
    Grotewiel MS; Chu H; Sanders-Bush E
    J Pharmacol Exp Ther; 1994 Nov; 271(2):1122-6. PubMed ID: 7965773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors.
    Conn PJ; Sanders-Bush E
    J Pharmacol Exp Ther; 1987 Aug; 242(2):552-7. PubMed ID: 3039120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin1c receptor reserve in choroid plexus masks receptor subsensitivity.
    Sanders-Bush E; Breeding M
    J Pharmacol Exp Ther; 1990 Mar; 252(3):984-8. PubMed ID: 2319481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in agonist-independent and -dependent 5-hydroxytryptamine2C receptor-mediated cell division.
    Westphal RS; Sanders-Bush E
    Mol Pharmacol; 1996 Mar; 49(3):474-80. PubMed ID: 8643087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of 5-HT1B, 5-HT2A and 5-HT2C receptors in the generalization of 5-HT receptor agonists to the ethanol cue in the rat.
    Maurel S; Schreiber R; De Vry J
    Behav Pharmacol; 1998 Jul; 9(4):337-43. PubMed ID: 10065922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mCPP-induced hyperactivity in 5-HT2C receptor mutant mice is mediated by activation of multiple 5-HT receptor subtypes.
    Dalton GL; Lee MD; Kennett GA; Dourish CT; Clifton PG
    Neuropharmacology; 2004 Apr; 46(5):663-71. PubMed ID: 14996544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine.
    Fiorella D; Helsley S; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 Dec; 122(3):237-43. PubMed ID: 8748393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study.
    Di Giovanni G; Di Matteo V; Di Mascio M; Esposito E
    Synapse; 2000 Jan; 35(1):53-61. PubMed ID: 10579808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic m-CPP on locomotion, hypophagia, plasma corticosterone and 5-HT2C receptor levels in the rat.
    Fone KC; Austin RH; Topham IA; Kennett GA; Punhani T
    Br J Pharmacol; 1998 Apr; 123(8):1707-15. PubMed ID: 9605579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
    Monte AP; Waldman SR; Marona-Lewicka D; Wainscott DB; Nelson DL; Sanders-Bush E; Nichols DE
    J Med Chem; 1997 Sep; 40(19):2997-3008. PubMed ID: 9301661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cycloalkanecarboxylic esters derived from lysergol, dihydrolysergol-I, and elymoclavine as partial agonists and antagonists at rat 5-HT2A receptors: pharmacological evidence that the indolo[4,3-fg]quinoline system of the ergolines is responsible for high 5-HT2A receptor affinity.
    Pertz HH; Milhahn H; Eich E
    J Med Chem; 1999 Feb; 42(4):659-68. PubMed ID: 10052973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells.
    Porter RH; Benwell KR; Lamb H; Malcolm CS; Allen NH; Revell DF; Adams DR; Sheardown MJ
    Br J Pharmacol; 1999 Sep; 128(1):13-20. PubMed ID: 10498829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes.
    Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S
    Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT2C receptor mediation of unconditioned escape behaviour in the unstable elevated exposed plus maze.
    Jones N; Duxon MS; King SM
    Psychopharmacology (Berl); 2002 Nov; 164(2):214-20. PubMed ID: 12404085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptors.
    Watson J; Brough S; Coldwell MC; Gager T; Ho M; Hunter AJ; Jerman J; Middlemiss DN; Riley GJ; Brown AM
    Br J Pharmacol; 1998 Dec; 125(7):1413-20. PubMed ID: 9884068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of m-chlorophenylpiperazine.
    Fiorella D; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 May; 119(2):222-30. PubMed ID: 7659770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m-CPP induced hypolocomotion does not interfere in the assessment of memory functions in rats.
    Khaliq S; Irfan B; Haider S; Haleem DJ
    Pak J Pharm Sci; 2008 Apr; 21(2):139-43. PubMed ID: 18390444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization.
    Westphal RS; Backstrom JR; Sanders-Bush E
    Mol Pharmacol; 1995 Aug; 48(2):200-5. PubMed ID: 7651352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behaviour in mice.
    Nunes-de-Souza V; Nunes-de-Souza RL; Rodgers RJ; Canto-de-Souza A
    Behav Brain Res; 2008 Feb; 187(1):72-9. PubMed ID: 17935799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells.
    Cussac D; Boutet-Robinet E; Ailhaud MC; Newman-Tancredi A; Martel JC; Danty N; Rauly-Lestienne I
    Eur J Pharmacol; 2008 Oct; 594(1-3):32-8. PubMed ID: 18703043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.